BridgeBio Pharma, Inc. (BBIO)
USD 32.31
(-1.73%)
USD 32.31
(-1.73%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 1.36 Billion USD | 1.26% |
| 2022 | 1.34 Billion USD | 1.09% |
| 2021 | 1.33 Billion USD | 853.72% |
| 2020 | 139.7 Million USD | 152.92% |
| 2019 | -263.98 Million USD | 30.82% |
| 2018 | -381.57 Million USD | -835.62% |
| 2017 | 51.87 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 1.25 Billion USD | -8.1% |
| 2024 Q2 | 1.18 Billion USD | 5.42% |
| 2023 Q1 | 1.32 Billion USD | -1.88% |
| 2023 Q4 | 1.36 Billion USD | 10.9% |
| 2023 FY | 1.36 Billion USD | 1.26% |
| 2023 Q3 | 1.22 Billion USD | -14.07% |
| 2023 Q2 | 1.43 Billion USD | 8.3% |
| 2022 Q3 | 1.23 Billion USD | -0.74% |
| 2022 FY | 1.34 Billion USD | 1.09% |
| 2022 Q4 | 1.34 Billion USD | 9.28% |
| 2022 Q2 | 1.24 Billion USD | -8.46% |
| 2022 Q1 | 1.35 Billion USD | 1.8% |
| 2021 Q1 | 911.33 Million USD | 552.33% |
| 2021 Q2 | 1.01 Billion USD | 11.71% |
| 2021 Q3 | 1.21 Billion USD | 19.7% |
| 2021 Q4 | 1.33 Billion USD | 9.33% |
| 2021 FY | 1.33 Billion USD | 853.72% |
| 2020 Q3 | 116.78 Million USD | 289.53% |
| 2020 Q1 | -284.52 Million USD | -7.78% |
| 2020 FY | 139.7 Million USD | 152.92% |
| 2020 Q4 | 139.7 Million USD | 19.63% |
| 2020 Q2 | -61.61 Million USD | 78.34% |
| 2019 FY | -263.98 Million USD | 30.82% |
| 2019 Q4 | -263.98 Million USD | 22.12% |
| 2019 Q3 | -338.95 Million USD | -54.91% |
| 2019 Q2 | -218.8 Million USD | 31.23% |
| 2019 Q1 | -318.16 Million USD | 16.62% |
| 2018 Q4 | -381.57 Million USD | 0.0% |
| 2018 FY | -381.57 Million USD | -835.62% |
| 2018 Q1 | 91.99 Million USD | 0.0% |
| 2017 FY | 51.87 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Keros Therapeutics, Inc. | -316.7 Million USD | 530.657% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 27.062% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | 8223.789% |
| AlloVir, Inc. | -62.69 Million USD | 2275.561% |
| Precigen, Inc. | -481 Thousand USD | 283655.717% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 878.35% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | 58964.355% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | 7464.544% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | 23374.795% |
| Acelyrin, Inc. | -216.9 Million USD | 728.808% |
| AbCellera Biologics Inc. | -55.94 Million USD | 2538.153% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | -1130.182% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | -10202.16% |
| Agenus Inc. | 274.13 Million USD | -397.528% |
| Dyadic International, Inc. | -6.37 Million USD | 21484.162% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | 8660.24% |
| Lantern Pharma Inc. | -21.7 Million USD | 6384.318% |
| Immix Biopharma, Inc. | -17.5 Million USD | 7889.373% |
| IO Biotech, Inc. | -140.69 Million USD | 1069.376% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | -11113.295% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | 1860.988% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | 1156.356% |
| Aadi Bioscience, Inc. | -55.86 Million USD | 2541.47% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | -2126.526% |
| Alkermes plc | -166.73 Million USD | 917.987% |
| Aptorum Group Limited | 1.35 Million USD | -100405.289% |
| Ardelyx, Inc. | 34.51 Million USD | -3851.967% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | -31766.893% |
| Bicycle Therapeutics plc | -481.46 Million USD | 383.281% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | -3671.543% |
| Chimerix, Inc. | -25.51 Million USD | 5445.076% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | -19473.595% |
| CRISPR Therapeutics AG | -150.84 Million USD | 1004.175% |
| Elevation Oncology, Inc. | -19.11 Million USD | 7234.13% |
| ESSA Pharma Inc. | -33.62 Million USD | 4156.629% |
| Fortress Biotech, Inc. | 7.66 Million USD | -17693.907% |
| Fortress Biotech, Inc. | 7.66 Million USD | -17693.907% |
| NextCure, Inc. | -6.47 Million USD | 21157.635% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | 2800.745% |
| Onconetix, Inc. | 5.33 Million USD | -25482.277% |
| Opthea Limited | 28.15 Million USD | -4743.845% |
| PDS Biotechnology Corporation | -32.7 Million USD | 4269.822% |
| GT Biopharma, Inc. | -1.02 Million USD | 133685.015% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | 1333.888% |
| ImmuCell Corporation | 10.99 Million USD | -12309.766% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | 984.812% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | 16064.824% |
| Incyte Corporation | -3.17 Billion USD | 142.956% |
| Jaguar Health, Inc. | 29.39 Million USD | -4540.546% |
| Janux Therapeutics, Inc. | 5.33 Million USD | -25455.612% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | 27883.724% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | 9943.411% |
| ContextLogic Inc. | -232 Million USD | 687.889% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | -7793.871% |
| MiMedx Group, Inc. | -33.9 Million USD | 4123.194% |
| MEI Pharma, Inc. | -3.7 Million USD | 36912.497% |
| Pyxis Oncology, Inc. | 10.19 Million USD | -13278.156% |
| Seer, Inc. | -4.24 Million USD | 32267.524% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | 24410.839% |
| Novavax, Inc. | -298.29 Million USD | 557.234% |
| Clearside Biomedical, Inc. | 14.08 Million USD | -9586.123% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | 21481.141% |
| VYNE Therapeutics Inc. | -30.46 Million USD | 4577.685% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 910.723% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | -743.258% |
| Psyence Biomedical Ltd. | 6.89 Million USD | -19682.198% |
| Vaxcyte, Inc. | -368.22 Million USD | 470.397% |
| C4 Therapeutics, Inc. | -55.61 Million USD | 2552.445% |
| Pharming Group N.V. | 109.8 Million USD | -1142.125% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 662.752% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | 7940.325% |
| PureTech Health plc | -167.19 Million USD | 915.746% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | -4807.362% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | 7464.544% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | 19309.901% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | 79212.703% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | 20148.552% |
| Senti Biosciences, Inc. | 1.74 Million USD | -78285.23% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 838.814% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | 22599.225% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | -1366960.911% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | -217082.006% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | 5774.181% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | 1265.271% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | -10801.631% |
| ChromaDex Corporation | -24.04 Million USD | 5771.586% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | 18055.542% |
| Caribou Biosciences, Inc. | -23.67 Million USD | 5860.455% |
| Precision BioSciences, Inc. | -85.41 Million USD | 1696.889% |
| Fate Therapeutics, Inc. | 61.66 Million USD | -2111.759% |
| Innoviva, Inc. | 255.56 Million USD | -433.686% |
| Summit Therapeutics Inc. | 34.67 Million USD | -3833.503% |
| GlycoMimetics, Inc. | -40.98 Million USD | 3427.857% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | 2112.161% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | 1117.238% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | 4823.964% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | 1810574.686% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | 4519.36% |
| Aptose Biosciences Inc. | -8.19 Million USD | 16743.402% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | 43688.851% |
| Soligenix, Inc. | -4.95 Million USD | 27644.709% |
| Century Therapeutics, Inc. | 847 Thousand USD | -160927.509% |
| Kura Oncology, Inc. | -20.11 Million USD | 6879.516% |
| TScan Therapeutics, Inc. | -40.92 Million USD | 3432.608% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | 16340.807% |
| Ocean Biomedical, Inc. | 1.82 Million USD | -74769.997% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | 42761.964% |
| Autolus Therapeutics plc | -186.59 Million USD | 830.927% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | 2866.313% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 594.537% |
| Eterna Therapeutics Inc. | 34.26 Million USD | -3880.107% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | -729.786% |
| GRI Bio, Inc. | -1.79 Million USD | 76125.808% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | 15283.079% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | 4201.101% |
| IGM Biosciences, Inc. | -72.6 Million USD | 1978.499% |
| INmune Bio, Inc. | -25.41 Million USD | 5467.372% |
| Heron Therapeutics, Inc. | 150.95 Million USD | -803.54% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | 2792.321% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | 8493.574% |
| Entero Therapeutics, Inc. | -2.88 Million USD | 47376.88% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | -3487.802% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | 3411.65% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | -4177.569% |
| Coherus BioSciences, Inc. | 377.95 Million USD | -260.868% |
| Verastem, Inc. | -37.27 Million USD | 3758.734% |
| Abeona Therapeutics Inc. | -9.07 Million USD | 15132.547% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | 2729.87% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | 9111.582% |
| Histogen Inc. | -7.48 Million USD | 18316.949% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | 6412.373% |
| Surrozen, Inc. | -32.66 Million USD | 4275.554% |
| Organovo Holdings, Inc. | -1.5 Million USD | 90604.512% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | 32546.935% |
| Ovid Therapeutics Inc. | 18.96 Million USD | -7093.502% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | -52036.965% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | -32717.685% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | 16373.459% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | 3239.595% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | 9456.631% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 530.54% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | 188990.535% |
| Apollomics, Inc. | -27.39 Million USD | 5078.657% |
| Amarin Corporation plc | -191.04 Million USD | 813.936% |
| Mesoblast Limited | 55.96 Million USD | -2337.151% |
| Turnstone Biologics Corp. | -14.58 Million USD | 9452.05% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | 5492.626% |
| Synaptogenix, Inc. | -28.66 Million USD | 4858.659% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | 145816.132% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | -2698.783% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | 158309.071% |
| Monopar Therapeutics Inc. | -7.26 Million USD | 18870.823% |
| Exelixis, Inc. | -73.05 Million USD | 1967.081% |
| Better Therapeutics, Inc. | -860 Thousand USD | 158693.372% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | 5779.853% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 665.065% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | -185196.291% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | 18436.626% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | -108664.195% |
| Gritstone bio, Inc. | 39.49 Million USD | -3353.793% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 1721.744% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | 51917.267% |
| Avid Bioservices, Inc. | 169.72 Million USD | -703.582% |
| Insmed Incorporated | 721.62 Million USD | -89.006% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | 15019.884% |
| MediWound Ltd. | -5.32 Million USD | 25727.64% |
| OmniAb, Inc. | 9.2 Million USD | -14720.2% |
| Alector, Inc. | -35.63 Million USD | 3927.21% |
| Seres Therapeutics, Inc. | 85.97 Million USD | -1486.469% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | 27776.603% |
| Zai Lab Limited | -775 Million USD | 275.987% |
| Revance Therapeutics, Inc. | 340.55 Million USD | -300.494% |
| Aura Biosciences, Inc. | -21.52 Million USD | 6436.367% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | 1753.617% |
| Immunic, Inc. | -45.34 Million USD | 3108.167% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 805.899% |
| Veracyte, Inc. | -203.82 Million USD | 769.157% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | -113.68% |
| FibroGen, Inc. | 56.76 Million USD | -2302.634% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | -15216.148% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | 48344.197% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | 65977.959% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 70.288% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | 40923.197% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | 921.807% |
| TG Therapeutics, Inc. | 17.86 Million USD | -7535.78% |
| Galecto, Inc. | -21.21 Million USD | 6528.653% |
| Calithera Biosciences, Inc. | -23.78 Million USD | 5834.299% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 13.094% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | 5673.321% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | 11952.811% |
| XBiotech Inc. | -200.02 Million USD | 781.873% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 1721.744% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | -30021.533% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | 3967.802% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | 1866.302% |
| Theravance Biopharma, Inc. | 5.69 Million USD | -23865.964% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 900.342% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | 1576.501% |
| Vaxxinity, Inc. | 10.13 Million USD | -13361.34% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | -85.246% |
| Gain Therapeutics, Inc. | -10.76 Million USD | 12766.789% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | 2167.898% |
| NexImmune, Inc. | -3.13 Million USD | 43624.518% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | 39602.814% |
| Marker Therapeutics, Inc. | -15.11 Million USD | 9125.626% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | 5132.852% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | 15294.908% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | 1094944.873% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | 3461.685% |
| Ainos, Inc. | 4.07 Million USD | -33345.98% |
| Pluri Inc. | 22.82 Million USD | -5874.432% |
| Prothena Corporation plc | -608.34 Million USD | 324.198% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | 1248.492% |
| Celularity Inc. | 65.19 Million USD | -1992.197% |
| Rallybio Corporation | -24.1 Million USD | 5758.879% |
| Cue Biopharma, Inc. | -33.81 Million USD | 4132.949% |
| MeiraGTx Holdings plc | -40.3 Million USD | 3484.207% |
| Omeros Corporation | 331.17 Million USD | -311.836% |
| Humacyte, Inc. | -22.48 Million USD | 6165.565% |
| Immunocore Holdings plc | -358.59 Million USD | 480.347% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | 5649.961% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | 4513.783% |
| Blueprint Medicines Corporation | 702.83 Million USD | -94.057% |
| CalciMedica, Inc. | -5.53 Million USD | 24763.707% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 824.632% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | 13453.27% |
| Scholar Rock Holding Corporation | -40.03 Million USD | 3506.606% |
| Sana Biotechnology, Inc. | -33.25 Million USD | 4201.594% |
| Pulmatrix, Inc. | -10.41 Million USD | 13193.05% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | 22919.19% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | 3675.856% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | 1324.307% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | 2375.295% |
| Cytokinetics, Incorporated | 642.37 Million USD | -112.323% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | 23522.686% |
| Nutriband Inc. | -251.65 Thousand USD | 542069.029% |
| Protara Therapeutics, Inc. | -34.11 Million USD | 4097.488% |
| Vor Biopharma Inc. | 4.3 Million USD | -31618.674% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 122.596% |
| Evogene Ltd. | -19.63 Million USD | 7046.638% |
| ProKidney Corp. | -56.23 Million USD | 2525.32% |
| Applied Therapeutics, Inc. | -48.67 Million USD | 2902.233% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | 14865.35% |
| CorMedix Inc. | -43.05 Million USD | 3267.999% |
| BioLineRx Ltd. | 7.33 Million USD | -18491.917% |
| Tango Therapeutics, Inc. | -27.46 Million USD | 5065.968% |
| Galectin Therapeutics Inc. | 46.14 Million USD | -2855.562% |
| Atai Life Sciences N.V. | -28.55 Million USD | 4875.905% |
| Renovaro Biosciences Inc. | 2.23 Million USD | -61047.064% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | 6077.836% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | -7590.46% |
| Sagimet Biosciences Inc. | -75.07 Million USD | 1916.745% |
| MediciNova, Inc. | -50.78 Million USD | 2785.72% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | 1830.732% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | 6063238.475% |
| GeoVax Labs, Inc. | -6.45 Million USD | 21237.299% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 782.562% |
| Biomea Fusion, Inc. | -166.57 Million USD | 918.817% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 862.063% |
| Mereo BioPharma Group plc | -51.46 Million USD | 2749.95% |
| Cullinan Oncology, Inc. | -94.84 Million USD | 1538.049% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 564.293% |
| Absci Corporation | -72.59 Million USD | 1978.706% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | -29770.85% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 681.778% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | 1547.711% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | 1525.246% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | 3590.653% |
| Allakos Inc. | -24.97 Million USD | 5561.073% |
| Imunon, Inc. | -4.21 Million USD | 32467.131% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | 9351.818% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | 1107.314% |
| BioAtla, Inc. | -109.01 Million USD | 1351.161% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | -185196.291% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | 145350.586% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | -11298.153% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | 6532.594% |
| XOMA Corporation | -29 Million USD | 4803.114% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | 8336.129% |
| Cara Therapeutics, Inc. | -9.01 Million USD | 15227.584% |
| aTyr Pharma, Inc. | -7.44 Million USD | 18409.881% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | 1194.309% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 755.206% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | 1767.791% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | 1570.309% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | 158843.994% |
| Akari Therapeutics, Plc | -3.84 Million USD | 35572.12% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | -83941.617% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 1.229% |
| Lexaria Bioscience Corp. | -1.18 Million USD | 114893.605% |
| UroGen Pharma Ltd. | 4.39 Million USD | -30961.33% |
| Sutro Biopharma, Inc. | 113.48 Million USD | -1101.878% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | -1895210.025% |
| Orgenesis Inc. | 21.78 Million USD | -6161.031% |
| Entera Bio Ltd. | -10.62 Million USD | 12931.903% |
| GH Research PLC | -78.07 Million USD | 1846.869% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | 6219.45% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | 5216.107% |
| Xencor, Inc. | 29.64 Million USD | -4500.941% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | 69340.263% |
| Replimune Group, Inc. | 1.41 Million USD | -96493.697% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | 557004.225% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | 1178.892% |
| Lexaria Bioscience Corp. | -1.18 Million USD | 114893.605% |
| Portage Biotech Inc. | -4.98 Million USD | 27482.112% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | 6063238.475% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | 2162.707% |
| OncoCyte Corporation | -6.56 Million USD | 20881.7% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | -151881.641% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | 30038.759% |
| Purple Biotech Ltd. | -14.13 Million USD | 9747.072% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | 5841.299% |
| scPharmaceuticals Inc. | -6.54 Million USD | 20938.854% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | 8270.917% |
| HilleVax, Inc. | -165.48 Million USD | 924.185% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | 53839.283% |
| Tharimmune, Inc. | -10.93 Million USD | 12572.42% |
| Genprex, Inc. | -6.73 Million USD | 20343.071% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 469.815% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | 1641.83% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | 97452.106% |
| Virios Therapeutics, Inc. | -3.31 Million USD | 41219.24% |
| OKYO Pharma Limited | -826.84 Thousand USD | 165052.083% |
| Savara Inc. | 153 Thousand USD | -891339.869% |
| Curis, Inc. | -23.88 Million USD | 5809.813% |
| Daré Bioscience, Inc. | -5.15 Million USD | 26542.934% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | 175857.978% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | 22070.087% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | -114997.3% |
| BeiGene, Ltd. | -2.25 Billion USD | 160.535% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | -10954.042% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 324.251% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 834.917% |
| Erasca, Inc. | -37.21 Million USD | 3764.83% |
| bluebird bio, Inc. | 108.57 Million USD | -1156.231% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | 106001.888% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | -260.108% |
| DBV Technologies S.A. | -126.98 Million USD | 1174.058% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | 106001.888% |
| Moderna, Inc. | -2.9 Billion USD | 146.918% |
| Vincerx Pharma, Inc. | -10.35 Million USD | 13275.261% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | 12649.715% |
| Molecular Templates, Inc. | 707 Thousand USD | -192814.144% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | 4447.655% |
| Travere Therapeutics, Inc. | 346.6 Million USD | -293.5% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | 1762.04% |
| Spruce Biosciences, Inc. | -91.73 Million USD | 1586.867% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | 4326.274% |
| Cogent Biosciences, Inc. | -34.37 Million USD | 4067.602% |
| MacroGenics, Inc. | -66.98 Million USD | 2136.132% |
| RenovoRx, Inc. | -1.17 Million USD | 116374.766% |
| Adicet Bio, Inc. | -138.78 Million USD | 1082.731% |
| Prime Medicine, Inc. | -27.94 Million USD | 4981.368% |
| Aditxt, Inc. | 18.12 Million USD | -7426.691% |
| Adagene Inc. | -87.62 Million USD | 1656.48% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | 32843.406% |
| Quantum-Si incorporated | -118.55 Million USD | 1250.42% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | -3688.093% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | 18348.176% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | 2911.649% |
| SciSparc Ltd. | -2.06 Million USD | 66148.571% |
| Vericel Corporation | 1.27 Million USD | -106705.247% |
| Revelation Biosciences, Inc. | -11.99 Million USD | 11473.724% |
| Minerva Neurosciences, Inc. | 41 Million USD | -3226.248% |
| Generation Bio Co. | 31.44 Million USD | -4237.01% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 877.755% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | 4510.643% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | -1069.798% |
| Invivyd, Inc. | -198.47 Million USD | 787.188% |
| Relay Therapeutics, Inc. | -90.27 Million USD | 1610.915% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | 56984.084% |
| Spero Therapeutics, Inc. | -70.79 Million USD | 2026.689% |
| Artelo Biosciences, Inc. | -6.82 Million USD | 20083.927% |
| 2seventy bio, Inc. | 181.71 Million USD | -650.573% |
| ADMA Biologics, Inc. | 90.06 Million USD | -1414.337% |
| Clene Inc. | 3.34 Million USD | -40735.419% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | 15116.488% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | 6440.491% |
| GeoVax Labs, Inc. | -6.45 Million USD | 21237.299% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 496.341% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | 5345.845% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | -667.678% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | 33434.49% |
| Finch Therapeutics Group, Inc. | 5 Million USD | -27167.153% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | 26283.586% |
| Vir Biotechnology, Inc. | -130.3 Million USD | 1146.708% |
| Evaxion Biotech A/S | 5.28 Million USD | -25698.056% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | 1311.626% |
| Verve Therapeutics, Inc. | -131.27 Million USD | 1138.982% |
| Trevena, Inc. | 2.25 Million USD | -60303.144% |
| Surrozen, Inc. | -32.66 Million USD | 4275.554% |
| Tyra Biosciences, Inc. | -51.51 Million USD | 2747.841% |
| Cingulate Inc. | 3.08 Million USD | -44144.024% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | 46538.645% |
| Unity Biotechnology, Inc. | 7.18 Million USD | -18877.362% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | 14779.471% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | 1819.429% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | 1137.567% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | 1392.285% |
| Clearmind Medicine Inc. | -3.94 Million USD | 34693.674% |
| Kronos Bio, Inc. | -36.05 Million USD | 3882.945% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | -14395.727% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | -93438.011% |
| Viking Therapeutics, Inc. | -54.25 Million USD | 2613.829% |
| Statera Biopharma, Inc. | 14.41 Million USD | -9360.77% |
| ImmunityBio, Inc. | 618.22 Million USD | -120.616% |
| Korro Bio, Inc. | -132.94 Million USD | 1125.931% |
| Kineta, Inc. | -4.54 Million USD | 30135.301% |
| BioVie Inc. | -17.73 Million USD | 7791.608% |
| Codexis, Inc. | -43.27 Million USD | 3252.002% |
| Celularity Inc. | 65.19 Million USD | -1992.197% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | 43138.908% |
| Celcuity Inc. | 6.78 Million USD | -20006.157% |
| Virax Biolabs Group Limited | -3.36 Million USD | 40632.71% |
| Cibus, Inc. | -8.07 Million USD | 16984.167% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | 32351.194% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | -29744.705% |
| IN8bio, Inc. | -16.38 Million USD | 8422.064% |
| Kodiak Sciences Inc. | -103.87 Million USD | 1413.023% |
| Annexon, Inc. | -193.75 Million USD | 803.932% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | -3788519.444% |
| Assembly Biosciences, Inc. | -17.49 Million USD | 7894.177% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | 38924.452% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | -29.369% |
| Eyenovia, Inc. | 1.25 Million USD | -108257.896% |
| Puma Biotechnology, Inc. | 26.9 Million USD | -4969.329% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | 42156.83% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | 4202.334% |
| Arcellx, Inc. | -296.95 Million USD | 559.292% |
| Cardiff Oncology, Inc. | -19.5 Million USD | 7092.223% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | 2416.608% |
| Regulus Therapeutics Inc. | -20.72 Million USD | 6680.32% |
| Moolec Science SA | 117.61 Thousand USD | -1159523.691% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | 3651.923% |
| Geron Corporation | 14.76 Million USD | -9139.909% |
| LAVA Therapeutics N.V. | -37.91 Million USD | 3696.98% |
| Royalty Pharma plc | 5.65 Billion USD | 75.895% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | 1064.427% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | 19613.811% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | 25532.386% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | 1069.156% |
| Humacyte, Inc. | -22.48 Million USD | 6165.565% |
| Structure Therapeutics Inc. | -124.33 Million USD | 1196.923% |
| 89bio, Inc. | -289.05 Million USD | 571.852% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | 5503.308% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | 76594.84% |
| Genelux Corporation | -6.89 Million USD | 19869.575% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | 4491.329% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | -1531.482% |
| Notable Labs, Ltd. | -9.77 Million USD | 14051.545% |
| Liquidia Corporation | -80.17 Million USD | 1801.136% |
| Mustang Bio, Inc. | -3.73 Million USD | 36607.04% |
| Immunovant, Inc. | -635.22 Million USD | 314.711% |
| Quantum-Si incorporated | -118.55 Million USD | 1250.42% |
| Arbutus Biopharma Corporation | -17.56 Million USD | 7865.332% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | 33020.661% |
| Vera Therapeutics, Inc. | 8.02 Million USD | -16891.441% |
| Acasti Pharma Inc. | -23 Million USD | 6028.724% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | 40605.205% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | 8493.574% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | 1090.201% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | 43865.872% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | 6234.864% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | 7445.054% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 905.718% |
| PepGen Inc. | -60.67 Million USD | 2348.068% |
| Moleculin Biotech, Inc. | -22.97 Million USD | 6036.207% |
| United Therapeutics Corporation | -507.7 Million USD | 368.643% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | 7231.146% |
| Solid Biosciences Inc. | -47.75 Million USD | 2956.341% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | 158309.071% |
| Immuneering Corporation | -54.94 Million USD | 2582.403% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | 32546.935% |
| Silo Pharma, Inc. | -3.52 Million USD | 38799.881% |
| Belite Bio, Inc | -87.27 Million USD | 1662.836% |
| XOMA Corporation | -29 Million USD | 4803.114% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | 2029.223% |
| Bionomics Limited | 227 Million USD | -500.812% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | 1272.927% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | 53945.361% |
| uniQure N.V. | -102.95 Million USD | 1424.808% |
| Cassava Sciences, Inc. | -121.13 Million USD | 1225.927% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | 32843.406% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | -3230.573% |
| Forte Biosciences, Inc. | -11.96 Million USD | 11502.918% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | 44179.342% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | -1286600.943% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | 42156.83% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | -15216.148% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | 18491.357% |
| Altimmune, Inc. | -134.48 Million USD | 1114.152% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | -588.614% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | 53945.361% |
| Compugen Ltd. | -12.9 Million USD | 10669.614% |
| Peak Bio, Inc. | 10.34 Million USD | -13090.35% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | 482044.523% |
| Benitec Biopharma Inc. | -50.58 Million USD | 2796.42% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | 1407.197% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | -6842.749% |
| Zura Bio Limited | -99.8 Million USD | 1466.554% |
| PolyPid Ltd. | 6.17 Million USD | -22005.397% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | -1740.128% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | -6842.749% |
| Instil Bio, Inc. | 75.35 Million USD | -1709.898% |
| argenx SE | -2.02 Billion USD | 167.226% |
| Immunome, Inc. | -97.02 Million USD | 1505.665% |
| Compass Therapeutics, Inc. | -22.49 Million USD | 6163.138% |
| Verona Pharma plc | -220.44 Million USD | 718.71% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | 2001.096% |
| Shattuck Labs, Inc. | -121.42 Million USD | 1223.257% |
| CervoMed Inc. | -7.79 Million USD | 17601.988% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 835.262% |
| Plus Therapeutics, Inc. | -4.37 Million USD | 31289.184% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | 1135.299% |
| Moolec Science SA | 117.61 Thousand USD | -1159523.691% |
| Enveric Biosciences, Inc. | -2.28 Million USD | 59711.744% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | -8478.88% |
| AnaptysBio, Inc. | -18.15 Million USD | 7614.203% |
| Design Therapeutics, Inc. | -18.15 Million USD | 7614.617% |
| Leap Therapeutics, Inc. | -70.38 Million USD | 2037.885% |
| NeurAxis, Inc. | 145.7 Thousand USD | -936003.638% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | -12043.011% |
| Lumos Pharma, Inc. | -28.49 Million USD | 4886.8% |
| Achilles Therapeutics plc | -126.92 Million USD | 1174.582% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | 2001.096% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | 208097.651% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | 6665.488% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | -93438.011% |
| Nutriband Inc. | -251.65 Thousand USD | 542069.029% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | 10455.349% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | 18432.03% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | -300.916% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | -5646.379% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 404.802% |
| Palisade Bio, Inc. | -12.06 Million USD | 11406.499% |
| Tourmaline Bio, Inc. | -140.31 Million USD | 1072.057% |
| Beam Therapeutics Inc. | -262.72 Million USD | 619.143% |
| Neurogene Inc. | -131.95 Million USD | 1133.612% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | -6151.847% |
| AEON Biopharma, Inc. | -4.88 Million USD | 28048.832% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 461.595% |
| Sesen Bio, Inc. | -112.55 Million USD | 1311.787% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | 1465.815% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | 58192.983% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | 3594.857% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | 1737.692% |
| Athira Pharma, Inc. | -88.99 Million USD | 1632.492% |
| Vaccinex, Inc. | -1.28 Million USD | 105993.09% |
| HCW Biologics Inc. | 2.85 Million USD | -47644.406% |
| XOMA Corporation | -29 Million USD | 4803.114% |
| Nektar Therapeutics | 210.24 Million USD | -548.736% |
| Arvinas, Inc. | -313.8 Million USD | 534.641% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | -83941.617% |
| Merus N.V. | -192.88 Million USD | 807.11% |
| Omega Therapeutics, Inc. | 59.98 Million USD | -2173.74% |
| Quince Therapeutics, Inc. | -6.93 Million USD | 19758.446% |
| Rezolute, Inc. | -68.16 Million USD | 2100.797% |
| Clene Inc. | 3.34 Million USD | -40735.419% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | 10442.785% |
| BeyondSpring Inc. | -13.75 Million USD | 10015.689% |
| Synlogic, Inc. | -6.68 Million USD | 20502.438% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | -120173.633% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | 16231.319% |
| Peak Bio, Inc. | 10.34 Million USD | -13090.35% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | 1754.82% |
| Krystal Biotech, Inc. | -350.23 Million USD | 489.426% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | -998.814% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 907.062% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | 43300.532% |
| MannKind Corporation | 143.89 Million USD | -847.82% |
| Ikena Oncology, Inc. | -109.15 Million USD | 1349.499% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | 18114.833% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | 4220.553% |
| Gossamer Bio, Inc. | 180.35 Million USD | -656.232% |
| CohBar, Inc. | -5.93 Million USD | 23097.216% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | 4684.856% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | -29770.85% |
| Legend Biotech Corporation | -949.39 Million USD | 243.66% |
| Mural Oncology plc | -255.84 Million USD | 633.102% |
| Biora Therapeutics, Inc. | 32.21 Million USD | -4133.751% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | 29053.654% |
| Disc Medicine, Inc. | -358.28 Million USD | 480.68% |
| Champions Oncology, Inc. | 4.81 Million USD | -28243.786% |
| REGENXBIO Inc. | 54.76 Million USD | -2390.328% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | 507302.49% |
| Anavex Life Sciences Corp. | -151.02 Million USD | 1003.103% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | 15234.289% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | 1790.447% |
| Vaxart, Inc. | -8.24 Million USD | 16650.212% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | 2818.023% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | 1172.54% |
| Cellectis S.A. | -43.85 Million USD | 3210.029% |
| Longeveron Inc. | -2.9 Million USD | 47001.754% |
| Repare Therapeutics Inc. | -107.85 Million USD | 1364.536% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | -40.844% |
| Inozyme Pharma, Inc. | 12 Million USD | -11262.071% |
| Revolution Medicines, Inc. | -608.2 Million USD | 324.251% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | 110986.423% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 614.453% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | 1008.832% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | 8816.706% |
| Anixa Biosciences, Inc. | -740 Thousand USD | 184411.216% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 114.261% |
| Denali Therapeutics Inc. | -74.86 Million USD | 1921.817% |
| Revelation Biosciences, Inc. | -11.99 Million USD | 11473.724% |
| Veru Inc. | 4.77 Million USD | -28433.721% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | 12227.894% |
| Cingulate Inc. | 3.08 Million USD | -44144.024% |
| Passage Bio, Inc. | 4.58 Million USD | -29647.067% |
| Context Therapeutics Inc. | -14.44 Million USD | 9538.888% |
| Exicure, Inc. | 5.84 Million USD | -23218.567% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 692.033% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | 3546.811% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | -8592.263% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | 2418.735% |
| Nuvalent, Inc. | -335.38 Million USD | 506.665% |
| ABVC BioPharma, Inc. | 1.73 Million USD | -78540.994% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | 1931.185% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | 15441.991% |
| OmniAb, Inc. | 9.2 Million USD | -14720.2% |
| Anew Medical, Inc. | 1.43 Million USD | -95113.705% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | -8225.744% |
| Lipocine Inc. | -4.75 Million USD | 28786.016% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | 1341.854% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | -8854.783% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | 2792.321% |
| G1 Therapeutics, Inc. | 24.89 Million USD | -5379.283% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | 20393.156% |
| Sage Therapeutics, Inc. | -65.82 Million USD | 2171.951% |
| Ocugen, Inc. | -32.52 Million USD | 4293.915% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | 1693.81% |
| Q32 Bio Inc. | -37.94 Million USD | 3694.137% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | 217282.006% |
| Alumis Inc. Common Stock | -13.52 Million USD | 10181.329% |
| Equillium, Inc. | -22.39 Million USD | 6191.028% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | 5434.414% |
| Coya Therapeutics, Inc. | -32.62 Million USD | 4280.319% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | 550249.446% |
| Galera Therapeutics, Inc. | 134.04 Million USD | -917.519% |
| Evelo Biosciences, Inc. | 3.19 Million USD | -42548.624% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | -415165.755% |
| Dominari Holdings Inc. | 195 Thousand USD | -699337.436% |
| Edesa Biotech, Inc. | -5.26 Million USD | 25995.696% |
| vTv Therapeutics Inc. | -8.91 Million USD | 15395.537% |
| Bio-Techne Corporation | 267.74 Million USD | -409.4% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | 8514.48% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | 1254.93% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | 16331.144% |
| Candel Therapeutics, Inc. | -12.65 Million USD | 10880.99% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 656.425% |
| Nkarta, Inc. | 57.29 Million USD | -2280.326% |
| BioCardia, Inc. | 212 Thousand USD | -643250.472% |
| Iterum Therapeutics plc | 13.43 Million USD | -10049.598% |